| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000021976 |
| Receipt No. | R000025333 |
| Official scientific title of the study | Clinical evaluation of DAILIES TOTAL 1 performance in a Japanese population. |
| Date of disclosure of the study information | 2016/04/20 |
| Last modified on | 2018/10/30 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Clinical evaluation of DAILIES TOTAL 1 performance in a Japanese population. | |
| Title of the study (Brief title) | Clinical evaluation of DAILIES TOTAL 1 performance in a Japanese population. | |
| Region |
|
|
| Condition | ||
| Condition | Habitual current daily disposable soft contact lenses wearers with symptoms of contact lens discomfort. | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this clinical study is to demonstrate non-inferiority of DAILIES TOTAL1 to 1-DAY ACUVUE TruEye for Investigator-rated successful lens centration in Japanese population. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Investigator-rated successful lens centration of Optimal after 7 to 13 days of wearing. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | DAILIES TOTAL 1, then 1-DAY ACUVUE TruEye | |
| Interventions/Control_2 | 1-DAY ACUVUE TruEye, then DAILIES TOTAL 1 | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Must sign an informed consent form;
Habitual current disposable contact lenses wearer. Symptoms of contact lens discomfort as defined by the Symptomatology (Eligibility) Questionnaire. Lenses within power range specified in the protocol. Vision correctable to 0.8 or 0.1 logMAR (logarithmic minimum angle of resolution) or better in each eye at distance with pre-study contact lenses at Visit 1. Willing to wear lenses every day or at least for a minimum of 10 days, 6 hours per day, every day if possible and attend all study visits. Other protocol-specified inclusion criteria may apply. |
|||
| Key exclusion criteria | Currently wearing DAILIES TOTAL 1 or 1-DAY ACUVUE TruEye sphere lenses.
Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear. Use of systemic or ocular medications in which contact lens wear could be contraindicated as determined by the investigator. Eye injury or surgery within 12 weeks immediately prior to enrollment. History of herpetic keratitis, ocular surgery or irregular cornea. Prior refractive surgery. Monocular (only 1 eye with functional vision) or fit with only 1 lens. Participation in any clinical trial within 30 days of the enrollment visit. Other protocol-specified exclusion criteria may apply. |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Motozumi Itoi |
| Organization | Dogenzaka Itoi Eye Clinic |
| Division name | Dogenzaka Itoi Eye Clinic |
| Address | 1-10-19 Dogenzaka Shibuya-ku, Tokyo |
| TEL | 03-5784-4616 |
| itoi@eyeacademy.net | |
| Public contact | |
| Name of contact person | Mitsugu Watanabe |
| Organization | Alcon Japan Ltd. |
| Division name | Phase IV, Clinical & Regulatory Affairs Division Medical Affairs |
| Address | 1-23-1 Toranomon, Minato-ku, Tokyo |
| TEL | 03-6899-5054 |
| Homepage URL | |
| mitsugu.watanabe@alcon.com | |
| Sponsor | |
| Institute | Alcon Japan Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Alcon Japan Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025333 |